• Publications
  • Influence
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer.
PURPOSE As treatment options expand for metastatic colorectal cancer (mCRC), a blood marker with a prognostic and predictive role could guide treatment. We tested the hypothesis that circulatingExpand
  • 1,443
  • 57
  • PDF
Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer.
BACKGROUND We demonstrated that circulating tumor cell (CTC) number at baseline and follow-up is an independent prognostic factor in metastatic colorectal cancer (mCRC). This analysis was undertakenExpand
  • 425
  • 14
Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines.
The NCCN Guidelines for Pancreatic Adenocarcinoma discuss the diagnosis and management of adenocarcinomas of the exocrine pancreas and are intended to assist with clinical decision-making. These NCCNExpand
  • 166
  • 13
  • PDF
Future directions in the treatment of neuroendocrine tumors: consensus report of the National Cancer Institute Neuroendocrine Tumor clinical trials planning meeting.
  • M. Kulke, L. Siu, +13 authors J. Yao
  • Medicine
  • Journal of clinical oncology : official journal…
  • 1 March 2011
Neuroendocrine tumors (NETs) arise from a variety of anatomic sites and share the capacity for production of hormones and vasoactive peptides. Because of their perceived rarity, NETs have notExpand
  • 249
  • 12
  • PDF
Changing patterns of bone and brain metastases in patients with colorectal cancer.
BACKGROUND Therapeutic advances for patients with metastatic colorectal cancer (CRC) have been associated with prolonged survival. This study was undertaken to test the hypothesis that expandedExpand
  • 164
  • 10
Global gene expression profiling of circulating tumor cells.
Metastases from primary tumors are responsible for most cancer deaths. It has been shown that circulating tumor cells (CTCs) can be detected in the peripheral blood of patients with a variety ofExpand
  • 248
  • 8
  • PDF
Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer.
PURPOSE Development of targeted therapeutic agents in colorectal cancer (CRC) is impeded by the lack of a noninvasive surrogate of drug effect. This pilot study evaluated the ability ofExpand
  • 184
  • 8
Fibroblast Activation Protein and Its Relationship to Clinical Outcome in Pancreatic Adenocarcinoma
Objectives: Given the extensive desmoplastic response associated with pancreatic adenocarcinoma, we hypothesized that the stromal protein fibroblast activation protein (FAP) would be highly expressedExpand
  • 153
  • 6
Pancreatic Adenocarcinoma, Version 2.2014
Abstract The NCCN Guidelines for Pancreatic Adenocarcinoma discuss the diagnosis and management of adenocarcinomas of the exocrine pancreas and are intended to assist with clinical decision-making.Expand
  • 262
  • 5
Multicenter evaluation of the safety and efficacy of radioembolization in patients with unresectable colorectal liver metastases selected as candidates for (90)Y resin microspheres.
BACKGROUND Metastatic colorectal cancer liver metastases Outcomes after RadioEmbolization (MORE) was an investigator-initiated case-control study to assess the experience of 11 US centers who treatedExpand
  • 72
  • 5
...
1
2
3
4
5
...